Citizens Maintains Market Outperform on Axogen, Raises Price Target to $42
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Citizens analyst David Turkaly maintains Axogen (NASDAQ:AXGN) with a Market Outperform and raises the price target from $34 to $42.
Citizens analyst David Turkaly maintains Axogen (NASDAQ:AXGN) with a Market Outperform and raises the price target from $34 to $42.